Improving Access to T1D Clinical Trials Webinar | Recording-Improving Access to T1D Clinical Trials Webinar

Video Transcription

Video Summary

In the webinar "Improving Access to T1D Clinical Trials," medical professionals discussed pivotal information regarding participation in Type 1 Diabetes clinical trials. The panel stressed the importance of these trials in advancing treatment options and highlighted that participation remains voluntary and informed consent is vital. Various phases of clinical trials were explained, from assessing safety (Phase 1) to evaluating effectiveness (Phase 2) and post-marketing studies (Phase 4). Barriers to trial participation were identified, particularly the lack of referrals by healthcare providers due to time constraints and insufficient information about active trials. The discussion emphasized the potential benefits of participation, which include contributing to scientific progress and frequently enhanced care from leading researchers. The panelists also pointed out the need for diverse participant representation to generalize findings and reduce health disparities. Suggestions to improve representation included engaging community partners beyond clinical settings. Strategies for patient-provider communication were shared to promote patient empowerment and shared decision-making. The session underscored the necessity of integrating discussions about clinical trials into clinical practice to accelerate advancements in Type 1 Diabetes care.

Keywords

Type 1 Diabetes

clinical trials

informed consent

trial participation barriers

diverse representation

patient empowerment

shared decision-making

healthcare providers

treatment advancements